논문 상세보기

Construction of graphene/AuNPs based amperometric immunosensor for detecting bladder cancer biomarker apolipoprotein A1 KCI 등재

Jing Yang, Xingyuan Wang, Tingting Zhou, Liangjun Wei, Meiling Guo, Yanan Liu, Xiaoqi Sun, Yanjie Wang
  • 언어ENG
  • URLhttps://db.koreascholar.com/Article/Detail/435109
구독 기관 인증 시 무료 이용이 가능합니다. 4,000원
Carbon Letters (Carbon letters)
한국탄소학회 (Korean Carbon Society)
초록

This paper presents the construction and characterization of an amperometric immunosensor based on the graphene/gold nanoparticles (AuNPs/GO) nanocomposite for the detection of the bladder cancer biomarker, apolipoprotein A1 (Apo-A1). The morphological analysis of the AuNPs/GO nanocomposite demonstrated an almost spherical shape of AuNPs and the successful coverage of their surface by graphene oxide. An increased G peak and decreased D peak after the association of AuNPs with GO, implied a reduction in graphene defects. The X-ray photoelectron spectroscopy (XPS) indicated a significant decrease in the quantity of oxygen-containing functional groups in the AuNPs/GO nanocomposite, as compared to the original GO. Furthermore, the developed sensor demonstrated commendable sensitivity and selectivity, with a wide linear range for Apo-A1 detection. Importantly, the immunosensor exhibited remarkable stability over a period of 14 days, signifying its potential for practical applications.

키워드
Amperometric immunosensorApolipoprotein A1Graphene oxideGold nanoparticlesBladder cancer biomarker
목차
Construction of grapheneAuNPs based amperometric immunosensor for detecting bladder cancer biomarker apolipoprotein A1
    Abstract
    1 Introduction
    2 Experimental
        2.1 Materials
        2.2 Preparation of GO
        2.3 Preparation of AuNPsGO nanocomposite
        2.4 Preparation of immunosensor
        2.5 Determination of Apo-A1
    3 Results and discussion
    4 Conclusion
    References
저자
  • Jing Yang(Harbin Medical University Cancer Hospital, Harbin 150000, Heilongjiang Province, China)
  • Xingyuan Wang(Harbin Medical University Cancer Hospital, Harbin 150000, Heilongjiang Province, China)
  • Tingting Zhou(Harbin Medical University Cancer Hospital, Harbin 150000, Heilongjiang Province, China)
  • Liangjun Wei(Harbin Medical University Cancer Hospital, Harbin 150000, Heilongjiang Province, China)
  • Meiling Guo(Harbin Medical University Cancer Hospital, Harbin 150000, Heilongjiang Province, China)
  • Yanan Liu(Harbin Medical University Cancer Hospital, Harbin 150000, Heilongjiang Province, China)
  • Xiaoqi Sun(Harbin Medical University Cancer Hospital, Harbin 150000, Heilongjiang Province, China)
  • Yanjie Wang(Harbin Medical University Cancer Hospital, Harbin 150000, Heilongjiang Province, China)